🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in co...
Status
Recruiting
Location
Keck Medicine of USC Buena Park
Start Date
2022-12-15
Trial ID
NCT05198830
Single arm, Phase II trial of concurrent Durvalumab (MEDI 4736) and radioth...
Status
Completed
Location
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
Start Date
2020-04-03
Trial ID
NCT04003246
Treatments Being Tested
This phase I/II trials investigates the side effects of olaparib and durval...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-01-05
Trial ID
NCT04728230
Treatments Being Tested
Combination treatment of Durvalumab with chemoradiotherapy is ongoing for h...
Status
Recruiting
Location
Severance Hospital
Start Date
2019-02-12
Trial ID
NCT03694236
Treatments Being Tested
This phase III trial compares the effect of immunotherapy (IO) with stereot...
Status
Recruiting
Location
Alta Bates Summit Medical Center-Herrick Campus
Start Date
2026-02-26
Trial ID
NCT07166406
This phase I trial studies the safety of adding durvalumab to accelerated h...
Status
Completed
Location
Grady Health System
Start Date
2019-10-28
Trial ID
NCT03801902